Skip to main content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Jpn J Cancer Res. 1998 Mar; 89(3): 254–261.
doi: 10.1111/j.1349-7006.1998.tb00556.x
PMCID: PMC5921805
PMID: 9600118

Influence of Drinking Green Tea on Breast Cancer Malignancy among Japanese Patients

Kei Nakachi,corresponding author1 Kimito Suemasu,2 Kenji Suga,1 Takeshi Takeo,2 Kazue Imai,1 and Yasuhiro Higashi2
Author information Article notes Copyright and License information PMC Disclaimer

Abstract

Inhibitory effects of green tea on carcinogenesis have been investigated in numerous laboratory studies using (–)‐epigallocatechin gallate (EGCG) or crude green tea extract, and there is also some epidemiologic evidence. Further, EGCG has been reported to inhibit the growth of cancer cells, lung metastasis in an animal model, and urokinase activity. In this study, we first examined the association between consumption of green tea prior to clinical cancer onset and various clinical parameters assessed at surgery among 472 patients with stage I, II, and III breast cancer. We found that increased consumption of green tea was closely associated with decreased numbers of axillary lymph node metastases among premenopausal patients with stage I and II breast cancer and with increased expression of progesterone receptor (PgR) and estrogen receptor (ER) among postmenopausal ones. Since these are potential prognostic factors, we then investigated the prognosis of breast cancer with special reference to consumption of green tea, in a follow‐up study of these patients. We found that increased consumption of green tea was correlated with decreased recurrence of stage I and II breast cancer (P<0.05 for crude disease‐free survival); the recurrence rate was 16.7 or 24.3% among those consuming ≥5 cups or ≥4 cups per day, respectively, in a seven‐year follow‐up of stage I and II breast cancer, and the relative risk of recurrence was 0.564 (95% confidence interval, 0.350–0.911) after adjustment for other lifestyle factors. However, no improvement in prognosis was observed in stage III breast cancer. Our results indicate that increased consumption of green tea prior to clinical cancer onset is significantly associated with improved prognosis of stage I and II breast cancer, and this association may be related to a modifying effect of green tea on the clinical characteristics of the cancer.

Keywords: Breast cancer, Green tea, Prognosis, Follow‐up study

Full Text

The Full Text of this article is available as a PDF (72K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

1. ) Imai , K. , Suga , K. and Nakachi , K.Cancer‐preventive effects of drinking green tea in a Japanese population . Prev. Med. , 26 , 769 – 775 ( 1997. ). [PubMed] [Google Scholar]
2. ) Imai , K. and Nakachi , K.Cross sectional study of effects of drinking green tea on cardiovascular and liver diseases . BMJ , 310 , 693 – 696 ( 1995. ). [PMC free article] [PubMed] [Google Scholar]
3. ) Yoshizawa , S. , Horiuchi , T. , Fujiki , H. , Yoshida , T. , Okuda , T. and Sugimura , T.Antitumor promotion activity of (–)‐epigallocatechin gallate, the main constituent of “tannin” in green tea . Phytother. Res. , 1 , 44 – 47 ( 1987. ). [Google Scholar]
4. ) Fujiki , H. , Yoshizawa , S. , Horiuchi , T. , Suganuma , M. , Yatsunami , J. , Nishiwaki , S. , Okabe , S. , Nishiwaki‐Matsushima , R. , Okuda , T. and Suganuma , T.Anticarcinogenic effects of (–)‐epigallocatechin gallate . Prev. Med. , 21 , 503 – 509 ( 1992. ). [PubMed] [Google Scholar]
5. ) Stick , H. F.Teas and tea components as inhibitors of carcinogen formation in model systems and man . Prev. Med. , 21 , 377 – 384 ( 1992. ). [PubMed] [Google Scholar]
6. ) Komori , A. , Yatsunami , J. , Okabe , S. , Abe , S. , Hara , K. , Suganuma , M. , Kim , S.J. and Fujiki , H.Anticarcinogenic activity of green tea polyphenols . Jpn. J. Clin. Oncol. , 23 , 186 – 190 ( 1993. ). [PubMed] [Google Scholar]
7. ) Wang , Z.Y. , Huang , M.T. , Ferraro , T. , Wong , C.Q. , Lou , Y.R. , Reuhl , K. , Iatropoulos , M. , Yang , C.S. and Conney , A.H.Inhibitory effect of green tea in drinking water on tumorigenesis by ultraviolet light and 12‐O‐tetradecanoylphorbol‐13‐acetate in the skin of SKH‐1 mice . Cancer Res. , 52 , 1162 – 1170 ( 1992. ). [PubMed] [Google Scholar]
8. ) Wang , Z.Y. , Agarwal , R. , Kahn , W.A. and Mukhtar , H.Protection against benzo(α)pyrene‐ and N‐nitrosodiethylamine‐induced lung and forestomach tumorigenesis in A/J mice by water extracts of green tea and licorice . Carcinogenesis , 13 , 1491 – 1494 ( 1992. ). [PubMed] [Google Scholar]
9. ) Yamane , T. , Takahashi , T. , Kuwata , K. , Oya , K. , Inagake , M. , Kitao , Y. , Suganuma , M. and Fujiki , H.Inhibition of N‐methyl‐N′‐nitrosoguanidine‐induced carcinogenesis by (–)‐epigallocatechin gallate in the rat glandular stomach . Cancer Res. , 55 , 2081 – 2084 ( 1995. ). [PubMed] [Google Scholar]
10. ) Narisawa , T. and Fukaura , Y.A very low dose of green tea polyphenols in drinking water prevents N‐methyl‐N‐nitrosourea‐induced colon carcinogenesis in F344 rats . Jpn. J. Cancer Res. , 84 , 1007 – 1009 ( 1993. ). [PMC free article] [PubMed] [Google Scholar]
11. ) Nishida , H. , Omori , M. , Fukutomi , Y. , Ninomiya , M. , Nishiwaki , S. , Suganuma , M. , Moriwaki , H. and Muto , Y.Inhibitory effects of (–)‐epigallocatechin gallate on spontaneous hepatoma in C3H/HeNCrj mice and human hepatoma‐derived PLC/PRF/5 cells . Jpn. J. Cancer Res. , 85 , 221 – 225 ( 1994. ). [PMC free article] [PubMed] [Google Scholar]
12. ) Xu , Y. , Ho , C.T. , Amin , S. G. , Han , C. and Chung , F.L.Inhibition of tobacco‐specific nitrosamine‐induced lung tumorigenesis in A/J mice by green tea and its major polyphenol as antioxidants . Cancer Res. , 52 , 3875 – 3879 ( 1992. ). [PubMed] [Google Scholar]
13. ) Fujiki , H. , Suganuma , M. , Okabe , S. , Sueoka , N. , Komori , A. , Sueoka , E. , Kozu , T. , Tada , Y. , Suga , K. , Imai , K. and Nakachi , K.Cancer inhibition by green tea . In“Special Issue of Mutation Research on the 5th International Conference on Mechanisms of Antimutagenesis and Anticarcinogenesis” ( 1997. ) in press . [PubMed]
14. ) Araki , R. , Inoue , S. , Osborne , M. P. and Telang , N. T.Chemoprevention of mammary preneoplasias. In vitro effects of a green tea polyphenol . Ann. N. Y. Acad. Sci. , 768 , 215 – 222 ( 1995. ). [PubMed] [Google Scholar]
15. ) Fujiki , H. , Suganuma , M. , Okabe , S. , Komori , A. , Sueoka , E. , Sueoka , N. , Kozu , T. and Sakai , Y.Japanese green tea as a cancer preventive in humans . Nutr. Rev. , 54 , s67 – s70 ( 1996. ). [PubMed] [Google Scholar]
16. ) Taniguchi , S. , Fujiki , H. , Kobayashi , H. , Go , H. , Miyado , K. , Sadano , H. and Shimokawa , R.Effect of (–)‐epigallocatechin gallate, the main constituent of green tea, on lung metastasis with mouse B16 melanoma cell lines . Cancer Lett. , 65 , 51 – 54 ( 1992. ). [PubMed] [Google Scholar]
17. ) Jankun , J. , Selman , S. H. , Swiercz , R. and Skrzypczak‐Jankun , E.Why drinking green tea could prevent cancer . Nature , 387 , 561 ( 1997. ). [PubMed] [Google Scholar]
18. ) Nakachi , K. , Imai , K. , Hayashi , S. and Kawajiri , K.Polymorphisms of the CYP1A1 and glutathione S‐transferase genes associated with susceptibility to lung cancer in relation to cigarette dose in a Japanese population . Cancer Res. , 53 , 2994 – 2999 ( 1993. ). [PubMed] [Google Scholar]
19. ) Nakachi , K. , Hayashi , S. , Kawajiri , K. and Imai , K.Association of cigarette smoking and CYP1A1 polymorphisms with adenocarcinoma of the lung by grades of differentiation . Carcinogenesis , 16 , 2209 – 2213 ( 1995. ). [PubMed] [Google Scholar]
20. ) Nakachi , K. and Imai , K.Epidemiology of genetic susceptibility and cigarette smoking in lung carcinogenesis by CYP1A1 polymorphisms . Gann Monogr. Cancer Res. , 44 , 195 – 205 ( 1996. ). [Google Scholar]
21. ) Suga , K. , Imai , K. , Sueoka , N. and Nakachi , K.Phase I clinical trial with green tea tablets in a Japanese healthy population . Cancer Prev. Int. , ( 1998. ), in press .
22. ) Torrisi , R. , Pensa , F. , Orengo , M. A. , Catsafados , E. , Ponzani , P. , Boccardo , F. , Costa , A. and Decensi , A.The synthetic retinoid fenretinide lowers plasma insulin‐like growth factor I levels in breast cancer patients . Cancer Res. , 53 , 4769 – 4771 ( 1993. ). [PubMed] [Google Scholar]
23. ) Hayashi , S. , Imai , K. , Suga , K. , Kurihara , T. , Higashi , Y. and Nakachi , K.Two promoters in expression of estrogen receptor messenger RNA in human breast cancer . Carcinogenesis , 18 , 459 – 464 ( 1997. ). [PubMed] [Google Scholar]
24. ) Hayashi , S. , Tanimoto , K. , Hajiro‐Nakanishi , K. , Tsuchiya , E. , Kurosumi , M. , Higashi , Y. , Imai , K. , Suga , K. and Nakachi , K.Abnormal FHIT transcripts in human breast carcinomas: a clinicopathological and epidemiological analysis of 61 Japanese cases . Cancer Res. , 57 , 1981 – 1985 ( 1997. ). [PubMed] [Google Scholar]
Articles from Japanese Journal of Cancer Research : Gann are provided here courtesy of Wiley
-